Elevance Health (ELV) Stock Price

Elevance Health Price

NYSE·CLOSED
379.13USD-3.64 (-0.96 %)
Market closed

Over the last 19 years Elevance Health grew revenue by 6.8% annually, reaching 199.13 B USD. Earnings per share have grown at 9.0% per year over the last 19 years. For Elevance Health, the net margin of 2.8% is down versus 4.4% a few years ago. At today's price the dividend yield works out to roughly 1.80%. The payout ratio is around 27% of earnings. The dividend has grown at 14.7% per year over the past 14 years. The consensus 12-month price target for Elevance Health is 400.86 USD, about 5.7% above where the stock trades today. Of 28 analysts, 16 rate the stock a buy — an overall Buy consensus. The stock trades about 37% above its 52-week low.

Elevance Health stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Elevance Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Elevance Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Elevance Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Elevance Health Stock Price History
DateElevance Health Price
8/4/2026379.13 USD
8/3/2026382.77 USD
7/31/2026375.84 USD
7/30/2026376.40 USD
7/29/2026381.38 USD
7/27/2026377.15 USD
7/23/2026379.31 USD
7/22/2026389.09 USD
7/21/2026393.44 USD
7/20/2026382.23 USD
7/17/2026373.11 USD
7/16/2026372.85 USD
7/15/2026390.33 USD
7/14/2026426.79 USD
7/13/2026424.60 USD
7/10/2026416.23 USD
7/9/2026420.39 USD
7/8/2026419.78 USD
7/7/2026418.85 USD
7/6/2026407.90 USD
7/2/2026417.89 USD
7/1/2026416.19 USD
6/30/2026386.73 USD
6/29/2026389.48 USD
6/26/2026395.18 USD
6/25/2026387.32 USD
6/24/2026384.00 USD
6/23/2026395.10 USD
6/22/2026395.02 USD
6/18/2026390.47 USD
6/17/2026393.45 USD
6/16/2026398.24 USD
6/15/2026404.12 USD
6/12/2026397.05 USD
6/11/2026398.86 USD
6/10/2026409.01 USD
6/9/2026424.43 USD
6/8/2026418.15 USD
6/5/2026412.35 USD
6/4/2026409.08 USD
6/3/2026390.99 USD
6/2/2026398.91 USD
6/1/2026398.57 USD
5/29/2026393.02 USD
5/28/2026390.11 USD
5/27/2026390.58 USD
5/26/2026386.45 USD
5/22/2026394.94 USD
5/21/2026392.62 USD
5/20/2026398.79 USD
5/19/2026402.27 USD
5/18/2026394.07 USD
5/15/2026392.68 USD
5/14/2026396.71 USD
5/13/2026399.64 USD
5/12/2026393.30 USD
5/11/2026381.75 USD
5/8/2026378.07 USD
5/7/2026372.92 USD
5/6/2026374.71 USD
5/5/2026369.07 USD
5/4/2026371.90 USD
5/1/2026372.68 USD
4/30/2026376.42 USD
4/29/2026376.63 USD
4/28/2026362.74 USD
4/27/2026356.13 USD
4/24/2026344.76 USD
4/23/2026346.29 USD
4/22/2026328.20 USD
4/21/2026328.11 USD
4/20/2026319.36 USD
4/17/2026323.05 USD
4/16/2026315.82 USD
4/15/2026311.18 USD
4/14/2026313.35 USD
4/13/2026316.07 USD
4/10/2026311.53 USD
4/9/2026316.87 USD
4/8/2026318.23 USD
4/7/2026311.83 USD
4/6/2026302.61 USD
4/5/2026302.61 USD
4/2/2026300.74 USD
4/1/2026300.74 USD
3/31/2026298.50 USD
3/30/2026292.75 USD
3/29/2026284.79 USD
3/27/2026286.39 USD
3/26/2026286.39 USD
3/25/2026294.25 USD
3/24/2026296.09 USD
3/23/2026290.33 USD
3/22/2026289.24 USD
3/20/2026291.48 USD
3/19/2026291.48 USD
3/18/2026291.15 USD
3/17/2026294.95 USD
3/16/2026295.75 USD
3/15/2026292.07 USD
3/13/2026291.63 USD
3/12/2026291.63 USD
3/11/2026287.89 USD
3/10/2026289.79 USD
3/9/2026282.68 USD
3/8/2026280.74 USD
3/6/2026289.64 USD
3/5/2026286.48 USD
3/4/2026291.45 USD
3/3/2026284.03 USD
3/2/2026294.07 USD
2/27/2026320.00 USD
2/26/2026323.05 USD
2/25/2026330.51 USD
2/24/2026327.14 USD
2/23/2026335.87 USD
2/20/2026342.93 USD
2/19/2026348.18 USD
2/18/2026346.24 USD
2/17/2026344.78 USD
2/13/2026346.80 USD
2/12/2026336.04 USD
2/11/2026330.25 USD
2/10/2026328.88 USD
2/9/2026327.50 USD
2/6/2026338.98 USD
2/5/2026326.52 USD
2/4/2026340.60 USD
2/3/2026336.45 USD
2/2/2026341.83 USD
1/30/2026345.74 USD
1/29/2026346.98 USD
1/28/2026341.85 USD
1/27/2026322.92 USD
1/26/2026358.01 USD
1/23/2026371.06 USD
1/22/2026372.25 USD
1/21/2026369.88 USD
1/20/2026367.51 USD
1/16/2026374.87 USD
1/15/2026381.93 USD
1/14/2026372.84 USD
1/13/2026370.68 USD
1/12/2026374.97 USD
1/9/2026372.83 USD
1/8/2026374.77 USD
1/7/2026366.69 USD
1/6/2026371.37 USD
1/5/2026363.51 USD
1/2/2026354.25 USD
12/31/2025350.55 USD
12/30/2025348.80 USD
12/29/2025348.38 USD
12/26/2025349.88 USD
12/24/2025343.30 USD
12/23/2025343.22 USD
12/22/2025344.27 USD
12/19/2025340.69 USD
12/18/2025344.60 USD
12/17/2025345.96 USD
12/16/2025351.90 USD
12/15/2025360.67 USD
12/12/2025359.07 USD
12/11/2025358.31 USD
12/10/2025341.04 USD
12/9/2025329.81 USD
12/8/2025330.61 USD
12/5/2025330.75 USD
12/4/2025333.49 USD
12/3/2025330.75 USD
12/2/2025330.92 USD
12/1/2025329.68 USD
11/28/2025338.26 USD
11/26/2025338.52 USD
11/25/2025336.27 USD
11/24/2025329.60 USD
11/21/2025321.73 USD
11/20/2025313.99 USD
11/19/2025316.63 USD
11/18/2025324.53 USD
11/17/2025330.91 USD
11/14/2025325.83 USD
11/13/2025328.28 USD
11/12/2025327.63 USD
11/11/2025315.60 USD
11/10/2025303.40 USD
11/7/2025317.78 USD
11/6/2025315.17 USD
11/5/2025318.08 USD
11/4/2025316.62 USD
11/3/2025313.19 USD
10/31/2025316.78 USD
10/30/2025321.80 USD
10/29/2025336.36 USD
10/28/2025339.40 USD
10/27/2025342.49 USD
10/24/2025342.01 USD
10/23/2025346.28 USD
10/22/2025340.94 USD
10/21/2025349.75 USD
10/20/2025354.07 USD
10/17/2025351.93 USD
10/16/2025348.18 USD
10/15/2025349.46 USD
10/14/2025350.23 USD
10/13/2025351.42 USD
10/10/2025341.51 USD
10/9/2025358.13 USD
10/8/2025362.34 USD
10/7/2025357.49 USD
10/6/2025349.94 USD
10/3/2025350.90 USD
10/2/2025340.24 USD
10/1/2025332.66 USD
9/30/2025323.12 USD
9/29/2025319.69 USD
9/28/2025319.69 USD
9/25/2025318.61 USD
9/24/2025316.70 USD
9/23/2025323.73 USD
9/22/2025317.89 USD
9/19/2025313.72 USD
9/18/2025315.77 USD
9/17/2025308.48 USD
9/16/2025310.00 USD
9/15/2025306.91 USD
9/12/2025314.20 USD
9/11/2025314.89 USD
9/10/2025306.75 USD
9/9/2025315.09 USD
9/8/2025308.16 USD
9/5/2025314.10 USD
9/4/2025308.38 USD
9/3/2025321.59 USD
9/2/2025322.33 USD
8/29/2025318.66 USD
8/28/2025310.01 USD
8/27/2025309.81 USD
8/26/2025310.03 USD
8/25/2025314.00 USD
8/22/2025317.01 USD
8/21/2025314.95 USD
8/20/2025310.00 USD
8/19/2025312.00 USD
8/18/2025309.32 USD
8/15/2025309.58 USD
8/14/2025305.01 USD
8/13/2025294.44 USD
8/12/2025292.48 USD
8/11/2025290.79 USD
8/8/2025294.00 USD
8/7/2025283.48 USD
8/6/2025280.50 USD
8/5/2025277.01 USD
Access this data via the Eulerpool API
Get Free API Key

Elevance Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
171.34 B USD
8.75 B USD
5.99 B USD
Jan 1, 2024
176.81 B USD
8.89 B USD
5.98 B USD
Jan 1, 2025
199.13 B USD
8.11 B USD
5.66 B USD
Jan 1, 2026 (e)
196.96 B USD
10.24 B USD
6.09 B USD
Jan 1, 2027 (e)
201.37 B USD
10.47 B USD
6.64 B USD
Jan 1, 2028 (e)
212.42 B USD
11.05 B USD
7.64 B USD
Jan 1, 2029 (e)
214.01 B USD
11.13 B USD
9.20 B USD
Jan 1, 2030 (e)
232.23 B USD
12.08 B USD
10.76 B USD

Elevance Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 1:40 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
79.2484.9890.0492.11104.21121.87138.64156.60171.34176.81199.13196.96201.37212.42214.01232.23
7.197.245.962.2913.1516.9413.7612.959.423.1912.62-1.092.245.480.758.51
22.8721.3519.7721.9421.5227.7525.9625.5127.4427.8525.5625.5625.5625.5625.5625.56
18.1218.1417.8020.2122.4333.8235.9939.9547.0149.2450.9050.3551.4854.3054.7159.36
5.365.424.995.846.737.718.958.458.758.898.1110.2410.4711.0511.1312.08
6.766.385.546.346.466.336.455.405.105.034.075.205.205.205.205.20
2.562.473.843.754.814.576.105.895.995.985.666.096.647.649.2010.76
-0.35-3.5555.61-2.3928.19-4.8933.51-3.441.58-0.12-5.327.619.0314.9520.4316.96
2.502.602.703.003.203.804.525.125.926.526.846.887.748.70––
42.864.003.8511.116.6718.7518.9513.2715.6210.144.910.5812.5012.40––
268.00268.70263.30262.30258.00251.10245.50241.20235.80231.10221.80221.80221.80221.80221.80221.80
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Elevance Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Elevance Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Elevance Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Elevance Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Elevance Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Elevance Health stock margins

The Elevance Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Elevance Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Elevance Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
25.96 %
6.45 %
4.40 %
Jan 1, 2022
25.51 %
5.40 %
3.76 %
Jan 1, 2023
27.44 %
5.10 %
3.49 %
Jan 1, 2024
27.85 %
5.03 %
3.38 %
Jan 1, 2025
25.56 %
4.07 %
2.84 %
Jan 1, 2026 (e)
25.56 %
5.20 %
3.09 %
Jan 1, 2027 (e)
25.56 %
5.20 %
3.30 %
Jan 1, 2028 (e)
25.56 %
5.20 %
3.59 %

Elevance Health Stock Revenue, EBIT, Earnings per Share

The Elevance Health earnings per share therefore indicates how much revenue Elevance Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
564.72 USD
36.44 USD
24.86 USD
Jan 1, 2022
649.23 USD
35.04 USD
24.44 USD
Jan 1, 2023
726.63 USD
37.09 USD
25.39 USD
Jan 1, 2024
765.08 USD
38.46 USD
25.88 USD
Jan 1, 2025
897.77 USD
36.57 USD
25.53 USD
Jan 1, 2026 (e)
876.95 USD
46.19 USD
27.13 USD
Jan 1, 2027 (e)
896.59 USD
47.22 USD
29.58 USD
Jan 1, 2028 (e)
945.77 USD
49.81 USD
34.00 USD

Elevance Health business model & stock analysis

Anthem Inc is one of the largest health insurers in the USA. The company was founded in 1940 in Indianapolis, Indiana and has grown over the years to become a multi-state healthcare company with more than 41 million customers and a revenue of over $100 billion. The company offers health insurance for individuals and businesses. It is divided into two main areas: health insurance and medical services. Anthem Health Insurance Anthem offers various types of health insurance, including plans for individuals, families, and employers. The plans vary by state and can be HMOs (Health Maintenance Organization), PPOs (Preferred Provider Organization), or EPOs (Exclusive Provider Organization). Anthem Medicaid Anthem Medicaid is a program for needy Americans that varies from state to state. The company offers these plans in 19 states, including California, Georgia, Indiana, Ohio, and Virginia. It covers basics such as medication, doctor's appointments, hospital stays, prenatal care, and children's care. Anthem Medicare Advantage Anthem Medicare Advantage is health insurance for individuals who are 65 years or older or disabled and receive Medicare. It is offered as an alternative to traditional Medicare and includes benefits such as prescription drugs, dental and vision aids, and fitness programs. Anthem Blue Cross Blue Shield Anthem Blue Cross Blue Shield is a brand of Anthem and offers health insurance in 14 states. The plans can be HMOs, PPOs, or traditional indemnity plans and offer a variety of benefits, including prescription drugs, dentists, and vision aids. Anthem Medical Services Anthem also offers a wide range of medical services, including prescription drug management, collaboration with hospitals and doctors, and providing health programs for employers. Anthem Prescription Management Anthem Prescription Management offers medical services for the management of prescription drugs. This includes cost savings for employers and patients, as well as protection against drug abuse and misuse. Anthem Clinical Services Anthem Clinical Services offers a wide range of medical services. These include disease management for asthma, diabetes, heart failure, and COPD, patient support programs, and health risk screenings. Anthem Business Model Anthem has a business model based on providing health insurance and medical services to individuals and employers. The company offers a variety of plans that vary from state to state and are tailored to the needs of customers. Anthem focuses on improving health initiatives and offers its customers both digital and personal support. Anthem Innovations Anthem is committed to investing in novel technologies and digital applications to improve the health and well-being of its customers. These innovations include the use of telemedicine, wearables, and health data to better support its customers. Anthem Partnerships Anthem has partnerships with various companies to expand its reach and services. These include partnerships with CVS Health, Fortinet, and Walmart. These partnerships are aimed at lowering costs for patients while improving the quality of healthcare. Anthem and COVID-19 Anthem has committed to protecting and improving the health of its customers during the COVID-19 pandemic. The company has expanded its telemedicine policy and offers virtual doctor visits to customers. Additionally, the company provides resources and support to customers to help them during these difficult times. In conclusion, Anthem Inc is a major health insurer in the USA that offers health insurance and medical services to individuals and employers. The company has a comprehensive portfolio of plans and medical services tailored to the needs of customers. Anthem has also committed to investing in innovations and digital applications to improve the healthcare of its customers.

Elevance Health SWOT Analysis

Strengths

Anthem Inc has a strong market presence and brand recognition, allowing it to attract a large customer base. The company has a diversified portfolio of health insurance products, including individual, group, and government-sponsored plans, which provides stability and flexibility. Anthem Inc also benefits from a robust network of healthcare providers, ensuring access to quality care for its members.

Furthermore, Anthem Inc has been investing in innovative technologies and digital platforms, enhancing customer experience and improving operational efficiency. The company's strong financial performance and solid balance sheet enable it to make strategic investments and pursue growth opportunities.

Weaknesses

One of the weaknesses of Anthem Inc is its dependency on a specific region for a significant portion of its revenue. This regional concentration exposes the company to risks associated with local economic conditions, regulatory changes, and competitive pressures.

Moreover, Anthem Inc faces challenges related to rising healthcare costs and the need to control medical expenses. The company may experience difficulties in negotiating contracts with healthcare providers to achieve cost savings.

Opportunities

Anthem Inc has opportunities to capitalize on the growing demand for healthcare services, as the population ages and requires more comprehensive coverage. The company could expand its offerings to include specialized insurance products or wellness programs targeting specific demographics or health conditions.

Additionally, Anthem Inc can leverage its technological capabilities to develop innovative solutions, such as telemedicine services or digital health applications, to improve access to care and enhance customer engagement.

Threats

Anthem Inc faces threats from intense competition within the health insurance industry. Rival companies are constantly vying for market share by offering competitive pricing and differentiated products and services.

Furthermore, Anthem Inc is exposed to regulatory risks, as changes in healthcare policies and legislation can impact the company's operations and financial performance. External factors like economic downturns or unexpected public health crises can also pose threats to Anthem Inc's business.

Elevance Health Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Elevance Health Employees
Details
Date
Elevance Health Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Elevance Health Segments

Elevance Health Revenue by Segment

  • Max

Reportable Segments
Details
Date
Reportable Segments
Jan 1, 2024
177.01 B USD

Elevance Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Elevance Health historical P/E ratio, EBIT multiple, and P/S ratio

Elevance Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Elevance Health shares outstanding

The number of shares of Elevance Health was 221.8 M in 2025. This indicates how many shares Elevance Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
245.50 M Stocks
Jan 1, 2022
241.20 M Stocks
Jan 1, 2023
235.80 M Stocks
Jan 1, 2024
231.10 M Stocks
Jan 1, 2025
221.80 M Stocks
Jan 1, 2026 (e)
221.80 M Stocks
Jan 1, 2027 (e)
221.80 M Stocks
Jan 1, 2028 (e)
221.80 M Stocks

Elevance Health stock splits

In Elevance Health's history, there have been no stock splits.

Elevance Health Dividend History

16 years of dividend payments · 14 consecutive increases

YearAnnual DividendYoY ChangePayments
20261.72USDYTD—1×
Mar 10, 20261.72USD↑ 0.6%1/1
20256.84USD↑ 4.9%4×
Mar 10, 20251.71USD↑ 4.9%1/4
Jun 10, 20251.71USD 0.0%2/4
Sep 10, 20251.71USD 0.0%3/4
Dec 5, 20251.71USD 0.0%4/4
20246.52USD↑ 10.1%4×
20235.92USD↑ 15.6%4×
20225.12USD↑ 13.3%4×
20214.52USD↑ 18.9%4×
20203.80USD↑ 18.7%4×
20193.20USD↑ 6.7%4×
20183.00USD↑ 11.1%4×
20172.70USD↑ 3.8%4×

Elevance Health dividend history and estimates

In 2025, Elevance Health paid a dividend amounting to 6.84 USD. Dividend means that Elevance Health distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
4.52 USD
0.00 USD
Jan 1, 2022
5.12 USD
0.00 USD
Jan 1, 2023
5.92 USD
0.00 USD
Jan 1, 2024
6.52 USD
0.00 USD
Jan 1, 2025
6.84 USD
0.00 USD
Jan 1, 2026 (e)
1.72 USD
5.16 USD
Jan 1, 2027 (e)
0.00 USD
7.74 USD
Jan 1, 2028 (e)
0.00 USD
8.70 USD

Elevance Health dividend payout ratio

In 2025, Elevance Health had a payout ratio of 26.79%. The payout ratio indicates the percentage of the company's profits that Elevance Health distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
18.18 %
Jan 1, 2022
20.95 %
Jan 1, 2023
23.32 %
Jan 1, 2024
25.20 %
Jan 1, 2025
26.79 %
Jan 1, 2026 (e)
25.36 %
Jan 1, 2027 (e)
26.16 %
Jan 1, 2028 (e)
25.60 %

Current Elevance Health forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
1.50 %
Buy
57.14 % (16)
Hold
42.86 % (12)
Sell
0.00 % (0)
12M Price Target
400.86
Last Price
379.13
Currency
USD
12M Return Potential
5.73 %
LTM Return
0 %

Elevance Health Analyst Rating Actions

DateFirmActionRatingReliability
7/17/2026
Leerink Partners
Leerink Partners
MaintainedMarket Perform–
7/16/2026
Wells Fargo
Wells Fargo
MaintainedOverweight56
7/16/2026
RBC Capital
RBC Capital
MaintainedSector Perform52
7/16/2026
Guggenheim
Guggenheim
MaintainedBuy30
7/16/2026
Barclays
Barclays
MaintainedOverweight33
7/16/2026
Baird
Baird
MaintainedNeutral–
7/14/2026
Truist Securities
Truist Securities
MaintainedBuy–
7/14/2026
TD Cowen
TD Cowen
MaintainedBuy60
7/13/2026
Wells Fargo
Wells Fargo
MaintainedOverweight56
7/9/2026
RBC Capital
RBC Capital
MaintainedSector Perform52

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Elevance Health Earnings Calls

2025

Elevance Health Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
7/22/20266.26USD-49.20 BUSD-2026 Q2
4/22/202610.77USD-48.85 BUSD-2026 Q1
1/28/20263.13USD-50.31 BUSD-2025 Q4
4/17/202410.55USD-43.45 BUSD-2024 Q1
1/23/20245.63USD-42.55 BUSD-2023 Q4
7/20/20227.82USD-38.70 BUSD-2022 Q2

EESG©

Eulerpool ESG Scorecard© for the Elevance Health stock

80/100
81
Environment
81
Social
79
Governance
E

Environment

20
Scope 1 - Direct Emissions18,854
Scope 2 - Indirect emissions from purchased energy86,057
Scope 3 - Indirect emissions within the value chain7,075,501
Total CO₂ emissions104,911
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees77
Percentage of women in management—
Percentage of Asian employees10
Share of Asian management—
Percentage of Hispanic/Latino employees14
Hispano/Latino Management share—
Percentage of Black employees24
Black Management Share—
Percentage of white employees49
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Elevance Health shareholder structure

% Name
8.85446%
BLACKROCK, INC.
BLACKROCK, INC.
6.38711%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
4.58090%
STATE STREET CORP
STATE STREET CORP
3.66364%
WELLINGTON MANAGEMENT GROUP LLP
WELLINGTON MANAGEMENT GROUP LLP
2.82995%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
2.62436%
SANDERS CAPITAL, LLC
SANDERS CAPITAL, LLC
...

Elevance Health Beneficial Ownership Filings (SEC 13D/G)

Free Float
99.8%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
10.10%
ATH Holding Company, LLC
ATH Holding Company, LLC
SEC ↗
10.10%
Anthem, Inc.
Anthem, Inc.
SEC ↗
9.99%
Companies, Inc.
Companies, Inc.
SEC ↗
8.90%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
8.51%
BlackRock for purposes of Schedule 13G filings.
BlackRock for purposes of Schedule 13G filings.
SEC ↗
8.40%
Dodge & Cox 94-1441976
Dodge & Cox 94-1441976
SEC ↗
7.80%
BlackRock, Inc.
BlackRock, Inc.
SEC ↗
7.79%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
7.13%
Vanguard Capital Management
Vanguard Capital Management
SEC ↗
5.20%
5.2%1
5.2%1
SEC ↗

Elevance Health Executives and Management Board

17 members · avg. age 61 · 29 % women

GB

Ms. Gail Boudreaux (64)

President, Chief Executive Officer, Director · since 2017

20.47 M USD

Management

MK

Mr. Mark Kaye (45)

Chief Financial Officer, Executive Vice President

6.87 M USD
PH

Mr. Peter Haytaian (55)

Executive Vice President and President, Carelon and CarelonRx

6.35 M USD
FN

Ms. Felicia Norwood (65)

Executive Vice President and President, Government Health Benefits

6.29 M USD
CK

Mr. Charles Kendrick (59)

Executive Vice President and President, Commercial and Specialty Health Benefits

5.79 M USD
RL

Mr. Ratnakar Lavu (54)

Executive Vice President and Chief Digital Information Officer

–
RP

Mr. Ronald Penczek (60)

Chief Accounting Officer, Controller

–

Board of Directors

RP

Mr. Ramiro Peru (69)

Independent Chairman of the Board

392,613.00 USD
BJ

Dr. Bahija Jallal (63)

Independent Director

392,613.00 USD
RS

Mr. Ryan Schneider (55)

Independent Director

376,374.00 USD
RC

Mr. R. Kerry Clark (72)

Independent Director

375,000.00 USD
RD

Mr. Robert Dixon (69)

Independent Director

352,613.00 USD
AN

Mr. Antonio Neri (57)

Independent Director

352,613.00 USD

Frequently asked questions about Elevance Health

The business model of Anthem Inc revolves around providing healthcare services and products to its customers. With its extensive network of healthcare professionals and facilities, Anthem Inc offers a broad range of health insurance plans and related services. The company focuses on delivering affordable and accessible healthcare solutions to individuals, families, and businesses, aiming to improve the overall health and well-being of its members. Through strategic partnerships, innovative technologies, and a customer-centric approach, Anthem Inc aims to enhance the quality and efficiency of healthcare delivery, ultimately contributing to the improvement of population health.

Anthem Inc is primarily active in the healthcare and health insurance industries.

The main competitors of Anthem Inc in the market include UnitedHealth Group, Aetna, Cigna, and Humana.

Anthem Inc is a leading health insurance company based in the United States. With a history dating back to 1944, Anthem has grown to become one of the largest providers of healthcare coverage, serving millions of customers nationwide. Originally known as WellPoint Health Networks Inc, the company rebranded as Anthem Inc in 2014. Anthem offers a wide range of health insurance plans for individuals, families, and employers. They are committed to improving the health and well-being of their members by providing innovative healthcare solutions. Anthem Inc has a strong presence in the healthcare industry, and their reputation for quality and reliability makes them a trusted choice for many individuals and businesses.

Anthem Inc has achieved several significant milestones throughout its history. Notably, the company was founded in 2004 as a result of the merger between WellPoint Health Networks Inc and Anthem Insurance Companies Inc. Since then, Anthem Inc has grown to become one of the largest health insurance providers in the United States, serving millions of members nationwide. Additionally, the company has consistently focused on innovation and technology, implementing digital solutions to enhance the overall healthcare experience. Furthermore, Anthem Inc has been recognized for its commitment to corporate social responsibility, actively supporting philanthropic initiatives and promoting diversity and inclusion.

Anthem Inc is primarily present in the United States.

Anthem Inc represents a strong corporate philosophy centered around improving the lives of individuals and communities. They value integrity, innovation, and diversity in their operations. The company aims to provide accessible healthcare and innovative solutions to enhance the well-being of their members. Anthem Inc believes in fostering a culture that values collaboration, accountability, and putting customers first. With their commitment to delivering high-quality care and promoting healthy living, Anthem Inc strives to be a trusted partner and advocate for their members' health and wellness.

Analysts currently set an average price target of 401.08 USD for the Elevance Health stock (median: 400.86 USD), implying +5.8 % versus the latest price. The consensus is based on 28 analyst ratings.

Elevance Health Analyst Price Targets 2026

28 analysts currently rate the Elevance Health stock: 16 recommend buying, 12 holding and 0 selling. For 2026, analysts expect Elevance Health to generate revenue of 196.96 B USD and earnings per share of 27.47 USD.

Elevance Health Analyst Price Targets 2026

Converted at the current exchange rate, the Elevance Health share trades at 328.95 EUR (379.13 USD).

The Elevance Health share (ELV) is listed on 10 stock exchanges, including: NYSE (ANTM), XETRA (A58.DE), Frankfurt (A58.F), München (A58.MU), Düsseldorf (A58.DU), London (0HG8.L), London (0HG8.L), SIX (Zürich) (A58.SW).

Anthem Inc is a leading company in the healthcare sector specializing in providing health and dental insurance, employee and Medicare plans, as well as hospital and practice management. The company's business model is based on providing health solutions and insurance to individuals, employers, and government agencies. Anthem Inc was founded in 1944 and is headquartered in Indianapolis, Indiana. Anthem Inc is divided into three main areas: commercial membership, Medicaid membership, and Medicare membership. Commercial membership is the largest area of the company, providing insurance coverage to individuals and employers. Anthem Inc offers individual plans tailored to the needs of individual customers, as well as group plans that can be used by companies to offer health insurance to their employees. The Medicaid division of Anthem Inc provides insurance coverage for individuals and families with low income who cannot afford private insurance. Medicaid is a state-managed insurance program, and Anthem Inc is one of the largest providers of Medicaid plans in the United States. The company offers Medicaid plans in 23 states. The Medicare division of Anthem Inc specializes in serving people over 65 years old and offers Medicare Advantage plans and Medicare supplement insurance. Medicare Advantage plans provide additional benefits such as fitness programs and prescription drug coverage, while Medicare supplement insurance fills gaps in Medicare coverage. Anthem Inc also offers a variety of products and services to support the healthcare management of businesses and insurers. This includes data analytics and artificial intelligence-based decision support systems to improve treatment quality while reducing costs. The company also offers wellness programs and hospital management services to assist its customers in managing and controlling healthcare costs. Anthem Inc has also developed a digital platform – Anthem Anywhere – that allows customers to access their insurance information and health records online, schedule appointments, and reorder prescription medications. The platform is available for both iOS and Android. Anthem Inc's business model is based on providing high-quality health insurance and services to customers in the United States. The company is a major player in the healthcare sector and can benefit from its extensive experience and numerous partnerships. With the development of innovative products and services, Anthem Inc is well-positioned to continue being successful in the future. Agree

The expected revenue of Elevance Health is 196.96 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Elevance Health is 6.09 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Elevance Health is currently 13.80. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Elevance Health stock.

The price-to-sales ratio (P/S) of Elevance Health is currently 0.43. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Elevance Health stock.

The Eulerpool Quality Score for Elevance Health is 6/10.

The ISIN of Elevance Health is US0367521038. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Elevance Health is A12FMV. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Elevance Health is ELV. The ticker symbol is used to trade Elevance Health shares on the stock exchange.

Over the past 12 months, Elevance Health paid a dividend of 6.84 USD . This corresponds to a dividend yield of about 1.80 %. For the coming 12 months, Elevance Health is expected to pay a dividend of 7.74 USD.

The current dividend yield of Elevance Health is 1.80 %.

Elevance Health pays a dividend, distributed in the months of , , , .

Elevance Health paid dividends every year for the past 15 years.

For the upcoming 12 months, dividends amounting to 7.74 USD are expected. This corresponds to a dividend yield of 2.04 %.

Elevance Health is assigned to the 'Health' sector.

To receive the latest dividend of Elevance Health from amounting to 1.72 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Elevance Health distributed 6.52 USD as dividends.

The dividends of Elevance Health are distributed in USD.

All fundamentals and in-depth analysis of Elevance Health

Our stock analysis for Elevance Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Elevance Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Elevance Health Stock
Elevance Health Revenue→
Elevance Health Stock
Elevance Health Net Income→
Elevance Health Stock
Elevance Health P/E→
Elevance Health Stock
Elevance Health P/S→
Elevance Health Stock
Elevance Health EBIT→
Elevance Health Stock
Elevance Health Dividend→
Elevance Health Stock
Elevance Health Directors Dealings→
Elevance Health Stock
Elevance Health Stocks→
Elevance Health Stock
Elevance Health Market capitalization→
Elevance Health Stock
Elevance Health Debt→
Elevance Health Stock
Elevance Health Liabilities→
Elevance Health Stock
Elevance Health Equity→
Elevance Health Stock
Elevance Health AAQS→
Elevance Health Stock
Elevance Health Employees→
Elevance Health Stock
Elevance Health ROE→
Elevance Health Stock
Elevance Health ROA→
Elevance Health Stock
Elevance Health ROCE→
Elevance Health Stock
Elevance Health News→
Elevance Health Stock
Elevance Health Analyst Price Targets→

Health Stocks

ElexxionElekta AB (publ)Eli Lilly and CoEledon PharmaceuticalsElicera TherapeuticsElectromedElicio TherapeuticselectroCore,Elite PharmaceuticalsElanco Animal HealthEloxx PharmaceuticalsElanAll Stocks A–Z →